Literature DB >> 27984472

Six-Month Follow-up of Supervised Spinal Stabilization Exercises for Low Back Pain in Adolescent Idiopathic Scoliosis.

Karina A Zapata1, Sharon S Wang-Price, Daniel J Sucato.   

Abstract

PURPOSE: To evaluate the effectiveness of 8 weeks of weekly spinal stabilization exercises compared with 1-time treatment in participants with adolescent idiopathic scoliosis and low back pain at a 6-month follow-up.
METHODS: Thirty-two participants were evaluated at a 6-month follow-up. The supervised group received weekly spinal stabilization exercises. The unsupervised group received a 1-time treatment and home exercise program.
RESULTS: Both groups improved in all outcome measures. The supervised group had significantly reduced Numeric Pain Rating Scale and Improved Global Rating of Change scores, but had no differences in the revised Oswestry Back Pain Disability Questionnaire, or Patient-Specific Functional Scale scores in comparison with the unsupervised group.

Entities:  

Mesh:

Year:  2017        PMID: 27984472     DOI: 10.1097/PEP.0000000000000325

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  3 in total

1.  Morphology and epidemiological study of idiopathic scoliosis among primary school students in Chaozhou, China.

Authors:  Zemin Cai; Ruibin Wu; Shukai Zheng; Zhaolong Qiu; Kusheng Wu
Journal:  Environ Health Prev Med       Date:  2021-07-03       Impact factor: 3.674

2.  Factors influencing adherence to an app-based exercise program in adolescents with painful hyperkyphosis.

Authors:  Karina A Zapata; Sharon S Wang-Price; Tina S Fletcher; Charles E Johnston
Journal:  Scoliosis Spinal Disord       Date:  2018-07-18

3.  Respiratory function, functional capacity, and physical activity behaviours in children and adolescents with scoliosis.

Authors:  Elena Amăricăi; Oana Suciu; Roxana Ramona Onofrei; Roxana Steliana Miclăuș; Radu Emil Iacob; Liliana Caţan; Călin Marius Popoiu; Simona Cerbu; Eugen Boia
Journal:  J Int Med Res       Date:  2019-12-31       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.